partneri think the guesstimate on phase 3 trial is 40 million...give or take a handful. chump change for big pharma. and sct has gotta have a partner here. same as it was prior to the 25 may waterfall.
sure was nice to see an nr without the word "but"in it. maybe the pipeline people are kicking some "but".
alan's got the ammo he needs for a decent shot on phase 3 meeting with fda. imo...he'll get it. The '"objective"...according to the june nr...was a meeting with fda in october. same as it was prior to 25 may waterfall. If october is correct....we'll likely get thumbs up (or down) in late december or early January, wouldn't ya think? Between that...and updates on 2a tbi trial....sct has milestones that can be measured. that's what will drive the sp.
and if sct passes the tests and gets to phase 3....you'd have to think they'd be a nice target for big pharma. 2011 oughta be real interesting....